Shapeways, Inc. (NYSE: SHPW), a global leader in the digital manufacturing industry, announced today the expansion of its medical customer base within its Enterprise Manufacturing Solutions business by securing two significant contracts. These strategic partnerships should generate revenue of approximately $2.5…
Impetus Grants, a nonprofit foundation dedicated to funding aging-related research that might otherwise be overlooked by traditional funding sources, announces a new round of matching funding. Hevolution Foundation, a global non-profit organization that provides grants and early-stage investments to incentivize research…
Anova Enterprises, Inc. (Anova), an organization dedicated to accelerating the development of promising treatments to market announced the FDA authorization of a Phase II clinical trial to re-assess a targeted treatment in light of newly discovered pharmacogenomic predictor data in…
ViroCell Biologics (“ViroCell” or the “Company”), a specialist Contract Development and Manufacturing Organisation (“CDMO”) in cell and gene therapy clinical trials, announces the appointment of Brian Collins as Chief Financial Officer (“CFO”). Brian brings a wealth of relevant experience to…
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced the appointment of James Robinson, former President and Chief Executive Officer (CEO) of Urovant Sciences, to its…
Oak Street Health, a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, is now welcoming patients at the new Midtown center at 1310 Broadway in Gary, IN. This is the…
DaVita Inc. today announced that its Board of Directors appointed a new independent director, Wendy Schoppert, to join the Board, effective as of July 14, 2023. “We’re pleased to welcome Wendy to DaVita’s board,” said Pam Arway, independent chair of the DaVita Inc. Board of…
NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal first quarter ending June 30, 2023. Fiscal 2024 First Quarter Highlights “We are pleased to report solid top…
NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced Kymera Independent Physicians multi-specialty group selected NextGen® Enterprise EHR – a powerful, all-encompassing electronic health record to expand access to care, while increasing clinical productivity, enriching patient experience, and…
Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it has received a top score of 100% in the 2023 Disability Equality Index® (DEI), a comprehensive benchmarking tool that measures disability inclusion in the workplace.…
The newest addition to the Siemens Healthineers Atellica in vitro diagnostics portfolio, the Atellica CI Analyzer for immunoassay and clinical chemistry testing, has received FDA clearance and is now available in many of the world’s major markets. Labs operating at low to…
Elevance Health, Inc. (NYSE: ELV) reported second quarter 2023 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share. “Our solid execution and continued progress of our strategy to become a lifetime trusted…